Comment
GSK speeds up the race to market first RSV vaccine for older adults
Biden’s directive on foreign biotech investments impacts manufacturers
Novo Nordisk targets FDA approval for once-weekly insulin after Phase III data
‘Twindemic’ risks warrant immediate steps in Europe and the US
A game of two halves for Roche’s recently approved wet AMD assets
In Depth
What Rishi Sunak can do for the UK pharma industry
Inside the European mass shift to data-driven health solutions
Chronic drug shortages signal difficult outlook for cardiovascular care
Can gene therapies for haemophilia defend their high price tags?
Trial termination analysis unveils a silver lining for patient recruitment
New dawn for the EU's joint procurement crisis response
Comment
GSK speeds up the race to market first RSV vaccine for older adults